Why was Jaguar Health, (JAGX) stock bullish in the after-hours session?

SPRO Stock
SPRO Stock

Jaguar Health, (JAGX) announced the results of the special meeting of Jaguar stockholders ‎held on December 9, 2020. As previously announced, the meeting was adjourned to ‎December 22, 2020.‎

Get the hottest stocks to trade ‎every day before the market opens 100% ‎free. Click here now. 

‎The Company’s stockholders approved two proposals at the Special Meeting. On November ‎‎6, 2020, the Company filed a definitive proxy statement regarding the Special Meeting on ‎Schedule 14A with the SEC. A free copy of Jaguar’s proxy statement and other SEC filings is ‎available on Jaguar’s corporate website (https://www.sec.gov).‎

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


Read More

As revealed last week, Jaguar Health, (JAGX) finished a road show with the Swiss ‎Development Forum, a sponsor of Post Pandemic Recovery Equity, a European special ‎purpose acquisition firm. The Business expects to create Napo EU, a subsidiary in Europe ‎focused on the production of crofelemer for diarrhoea associated with ‘long-hauler’ post-‎COVID-19 recovery patient syndrome, in order to achieve a possible merger with SPAC, ‎which intends to invest between EUR 20 million and EUR 50 million. Napo EU will be ‎licenced exclusively to Crofelemer for Europe, the company’s latest patented medicinal ‎medicine, which will be needed to produce crofelemer for inflammatory diarrhoea and HIV-‎related diarrhoea indications.‎‎

Get the hottest stocks to trade every day before the ‎market opens 100% ‎free. Click here now. 

‎The Swiss Development ‎Forum is holding an investor webinar on Napo EU and SPAC on Wednesday 23 December at ‎‎10:30 AM Eastern. By clicking here, investors wanting to take part in the webinar are ‎encouraged to participate.‎


Please enter your comment!
Please enter your name here